No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Longboard Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group
Express News | Longboard Pharmaceuticals Inc : Evercore ISI Raises Target Price to $57 From $44
Cantor Fitzgerald Reiterates Overweight on Longboard Pharmaceuticals, Maintains $60 Price Target
Evercore ISI Raises Price Target on Longboard Pharmaceuticals to $57 From $44, Maintains Outperform Rating
Longboard Pharmaceuticals Price Target Raised to $36.00/Share From $30.00 by B. Riley Securities
Longboard Pharmaceuticals Is Maintained at Buy by B. Riley Securities